Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Professor James has studied brain tumor molecular biology and therapeutics for 25+ years, during which time he has authored more than 150 peer-reviewed reports. He has served on the editorial boards for the Clinical Cancer Research, Journal of Neuropathology & Experimental Neurology, and the International Journal of Oncology, and he is a Senior Editor for Neuro-Oncology. Dr. James is a member of the Scientific Advisory Committees for the Pediatric Brain Tumor Foundation and the National Brain Tumor Society, and h e has served on numerous review committees for the NIH, including his current membership with the CNBT study section.
Commentary: Immunotherapy (Los Angel) 2016, 2: 125